Skip to main content

MET 42

NCT03537508

MET 42

Associated Conditions

VaccineMeningococcal

Principal Investigator

Sponsor

Sanofi Pasteur

The main purpose of this study is to find out if the MenACYW conjugate vaccine is safe and protective of meningococcal disease in young children when given at the same time as the US recommended vaccine Menveo. Lab samples will be drawn to test how the body is responding to the vaccine. Subjects will also receive the recommended vaccines required under the normal vaccine schedule.

This study is currently enrolling.